ERIS LIFESCIENCES
Back to Cashflow Statement
|
ERIS LIFESCIENCES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹1,065 Cr | ₹486 Cr | ₹292 Cr | ₹378 Cr | ₹375 Cr |
What is the latest Cash Flow from Operating Activities ratio of ERIS LIFESCIENCES ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹1,065 Cr |
| Mar2024 | ₹486 Cr |
| Mar2023 | ₹292 Cr |
| Mar2022 | ₹378 Cr |
| Mar2021 | ₹375 Cr |
How is Cash Flow from Operating Activities of ERIS LIFESCIENCES Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,065 Cr | 119.13 | |
| Mar2024 | ₹486 Cr | 66.59 | |
| Mar2023 | ₹292 Cr | -22.87 | |
| Mar2022 | ₹378 Cr | 0.77 | |
| Mar2021 | ₹375 Cr | - | |
Compare Cash Flow from Operating Activities of peers of ERIS LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ERIS LIFESCIENCES | ₹22,906.8 Cr | 6.9% | 5.8% | 22% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,370.0 Cr | 1.2% | 5.5% | 0.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,802.0 Cr | -1.8% | -3.1% | 8.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹125,841.0 Cr | -2% | 2.8% | 19.2% | Stock Analytics | |
| CIPLA | ₹121,481.0 Cr | -0.7% | -8.6% | 2.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,220.0 Cr | -1.5% | -4.3% | 2.5% | Stock Analytics | |
ERIS LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ERIS LIFESCIENCES | 6.9% |
5.8% |
22% |
| SENSEX | -0.1% |
0.6% |
9.8% |
You may also like the below Video Courses